Cosmo Pharmaceuticals NV
OTC:CMOPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
OTC:CMOPF
|
IE |
|
C
|
CITIC Heavy Industries Co Ltd
SSE:601608
|
CN |
|
P
|
Pexip Holding ASA
DUS:4W9
|
NO |
|
Brazilian Critical Minerals Ltd
ASX:BCM
|
AU |
|
M
|
Mayora Indah Tbk PT
XMUN:D7V
|
ID |
|
C
|
Chibougamau Independent Mines Inc
F:CLL1
|
CA |
|
Asseco Poland SA
F:SFB1
|
PL |
|
F
|
FirstGroup PLC
DUS:FGR
|
UK |
|
Z
|
ZIGUP PLC
F:21W
|
UK |
|
B
|
BlockchainK2 Corp
F:KRL2
|
CA |
|
K
|
Kohls Corp
F:KHP
|
US |
|
B
|
Banca Generali SpA
XMUN:B7A
|
IT |
|
B
|
Benguet Corp
XPHS:BCB
|
PH |
|
Zoetis Inc
NYSE:ZTS
|
US |
|
C
|
Compania Introductora de Buenos Aires SA
BCBA:INTR
|
AR |
|
Cairo Communication SpA
F:CI1A
|
IT |
|
Donkeyrepublic Holding A/S
F:6UJ
|
DK |
|
J
|
Jorjin Technologies Inc
TPEX:4980
|
TW |
|
Drug Free Solution Inc
OTC:DSOL
|
US |
|
S
|
Swedish Orphan Biovitrum AB (publ)
XMUN:B6E
|
SE |
|
SLJ Global Tbk PT
F:LF9
|
ID |
|
M
|
ME Group International PLC
F:PHQ
|
UK |
|
A
|
Amines and Plasticizers Ltd
NSE:AMNPLST
|
IN |
|
Benz Mining Corp
XTSX:BZ
|
CA |
Dividends
Dividend Yield
Cosmo Pharmaceuticals NV
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Cosmo Pharmaceuticals NV
CMOPF have decreased by 0%.
Payout Ratio
Cosmo Pharmaceuticals NV
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for CMOPF is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CMOPF Price
Cosmo Pharmaceuticals NV
| Average Annual Return | 8.91% |
| Standard Deviation of Annual Returns | 57.99% |
| Max Drawdown | -63% |
| Market Capitalization | 812.8m USD |
| Shares Outstanding | 16 064 200 |
| Percentage of Shares Shorted |
N/A
|
